CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Lipocine Inc.

For profitWebsite ↗

Also known as: Chief Medical Director, Lipocine, Inc. | Lipocine Inc. | LIPOCINE INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Jun 16, 2025

Timeline

1990s

Jun 1, 1997
Lipocine Inc.— Founded

2020s

Dec 8, 2020
testosterone— Marketing Organization

Drugs by trial phase (2 distinct, 8 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

testosterone

Recent trials (12)

NCT06979544Lead sponsorPhase 3Jun 16, 2025
NCT04874350Lead sponsorPhase 2Sep 30, 2021
NCT04685993Lead sponsorPhase 2Nov 11, 2020
NCT04134091Lead sponsorPhase 2Aug 27, 2019
NCT03868059Lead sponsorPhase 3Apr 30, 2018
NCT03868059Study directorPhase 3Apr 30, 2018
NCT03242408Study directorPhase 3Jan 31, 2017
NCT03242408Lead sponsorPhase 3Jan 31, 2017
NCT03242590Lead sponsorPhase 3Dec 31, 2016
NCT03242590Study directorPhase 3Dec 31, 2016
NCT02081300Study directorPhase 3Feb 1, 2014
NCT02081300Lead sponsorPhase 3Feb 1, 2014

Details

Founded: Salt Lake City, UT, US Jun 1, 1997
Last known activity: Jun 16, 2025